Herantis Pharma Oyj (HEL: HRTIS)
Finland flag Finland · Delayed Price · Currency is EUR
1.650
-0.010 (-0.60%)
Dec 20, 2024, 5:59 PM EET

Herantis Pharma Oyj Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
333228274052
Upgrade
Market Cap Growth
16.40%13.79%4.72%-34.19%-21.79%91.39%
Upgrade
Enterprise Value
303125263953
Upgrade
Last Close Price
1.651.571.652.283.957.37
Upgrade
PE Ratio
-113.47----
Upgrade
Forward PE
----1.42-
Upgrade
PB Ratio
16.316.72-462.92-23.375.3427.97
Upgrade
P/TBV Ratio
16.416.72--5.3427.97
Upgrade
EV/EBIT Ratio
-203.31----
Upgrade
Debt / Equity Ratio
0.010.02-75.33-6.430.953.90
Upgrade
Quick Ratio
2.283.383.252.894.673.60
Upgrade
Current Ratio
2.303.393.282.914.683.61
Upgrade
Return on Equity (ROE)
-661.79%11.99%--396.06%-193.95%-908.72%
Upgrade
Return on Assets (ROA)
-2.75%1.49%-71.40%-64.41%-36.70%-49.09%
Upgrade
Return on Capital (ROIC)
-5.09%2.08%-93.60%-74.22%-42.29%-58.23%
Upgrade
Earnings Yield
-1.97%0.88%-33.41%-47.91%-22.60%-15.46%
Upgrade
FCF Yield
-17.79%-14.60%-32.05%-37.28%-21.14%-11.51%
Upgrade
Buyback Yield / Dilution
-10.24%-17.34%-43.59%-38.03%-26.51%-18.83%
Upgrade
Total Shareholder Return
-10.24%-17.34%-43.59%-38.03%-26.51%-18.83%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.